HFE hemochromatosis: an overview about therapeutic recommendations
Hematol., Transfus. Cell Ther. (Impr.)
;
44(1): 95-99, Jan.-Mar. 2022. tab
Artigo
em Inglês
| LILACS
| ID: biblio-1364881
ABSTRACT
Abstract Hemochromatosis is currently characterized by the iron overload caused by hepcidin deficiency. Large advances in the knowledge on the hemochromatosis pathophysiology have occurred due to a better understanding of the protein of the iron metabolism, the genetic basis of hemochromatosis and of other iron overload diseases or conditions which can lead to this phenotype. In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Distúrbios do Metabolismo do Ferro
/
Hemocromatose
Tipo de estudo:
Guia de Prática Clínica
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Hematol., Transfus. Cell Ther. (Impr.)
Assunto da revista:
Hematologia
/
TransfusÆo de Sangue
Ano de publicação:
2022
Tipo de documento:
Artigo
País de afiliação:
Brasil
Instituição/País de afiliação:
Santa Casa de São Paulo/BR
/
Universidade Federal de São Paulo - UNIFESP/BR
Similares
MEDLINE
...
LILACS
LIS